Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy
Authors:
- 1 November 1996
- journal article
- research article
- Published by Elsevier in Reproductive Toxicology
- Vol. 10 (6) , 439-446
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Maternal Hyperlipidemia in PregnancyClinical Obstetrics and Gynecology, 1994
- Congenital abnormalities (VATER) in baby born to mother using lovastatinThe Lancet, 1992
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductaseTeratology, 1983
- Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.Journal of Clinical Investigation, 1982
- The VATER associationThe Journal of Pediatrics, 1973